CRIS Curis, Inc.
$1.13▼ -2.59%
Healthcare
Other
After hours
$1.23▲ +8.99%
Sep 11, 7:51 PM ET
Volume 128.3K
Avg Volume (10D) 129.5K
Key Metrics & Fundamentals
Market Cap
$2.74M
P/E Ratio
0.3
Div Yield
–%
52W Range
1.11 - 37.60
% vs 50 MA
-66.19%
% vs 200 MA
-91.18%
RSI-14
19.1
MACD Histogram
+0.1100
Beta (1Y vs SPY)
1.96
Free Cash Flow
-$9.65M
Gross Rev
$0
Gross Profit
$0
EBITDA
-$11.23M
COGS
$0
Operating Exp
$9.94M
Operating Income
-$9.94M
EBIT
-$9.94M
Pretax Income
-$8.58M
Net Income
-$8.58M
EPS (Diluted)
-4.02
Price & Volume History
Loading chart…
Recent News
VISTA Inhibitor Market Insights Report 2026 | Featuring Profiles of Aurigene Discovery Technologies, Curis, Hummingbird Bioscience, Kineta, PharmAbcine
GlobeNewswire · Aug 26, 2026 2:16 PM
Curis: Q2 Earnings Snapshot
Associated Press · Aug 14, 2026 8:16 PM
Curis Prices $5.6 Million Public Offering With Healthcare-Focused Institutional Investors
MT Newswires · Aug 13, 2026 1:28 PM
Curis, Inc. Announces Pricing of $5.6 Million Public Offering
PR Newswire · Aug 13, 2026 12:00 PM
Curis (CRIS) Stock Fair Value Moves Lower After Emavusertib TakeAim Model Rework
Simply Wall St. · Aug 5, 2026 5:11 PM
Curis Doses First Five Patients in TakeAim CLL Study
PR Newswire · Jul 30, 2026 12:00 PM
Curis Gains As Blood Cancer Drug Progresses, December Readout in Focus
Benzinga · Jul 27, 2026 4:30 PM
Curis (CRIS) Stock Sees Fair Value Lift As Analysts Back Leadership And Consumer Focus
Simply Wall St. · Jul 22, 2026 4:12 PM
Curis shares surge after updated emavusertib data strengthens clinical outlook (NASDAQ:CRIS)
InvestorsHub · Jul 22, 2026 12:25 PM
Curis Announces Positive Emavusertib Update
PR Newswire · Jul 22, 2026 11:00 AM
Financial Overview - Income Statement
Quarterly
Dec 2025
See CRIS's money flow as a full page
Social Sentiment
No Reddit posts found for CRIS.
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.